{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:26:48Z","timestamp":1759332408832},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T00:00:00Z","timestamp":1241481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s12032-009-9223-y","type":"journal-article","created":{"date-parts":[[2009,5,4]],"date-time":"2009-05-04T22:30:19Z","timestamp":1241476219000},"page":"392-396","source":"Crossref","is-referenced-by-count":9,"title":["Salvage chemotherapy with amrubicin and platinum for relapsed thymic carcinoma: experience in six cases"],"prefix":"10.1007","volume":"27","author":[{"given":"Tomonobu","family":"Koizumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Agatsuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ichiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhito","family":"Ushiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimichi","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumiko","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Yasuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Hachiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,5]]},"reference":[{"key":"9223_CR1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F","volume":"67","author":"S Suster","year":"1991","unstructured":"Suster S, Rosai J. Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer. 1991;67:1025\u201332. doi: 10.1002\/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F .","journal-title":"Cancer"},{"key":"9223_CR2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0022-5223(94)70112-1","volume":"107","author":"CP Hsu","year":"1994","unstructured":"Hsu CP, Chen CY, Hsu NY, Wang JH, Wang PY. Thymic carcinoma. Ten years\u2019 experience in twenty patients. J Thorac Cardiovasc Surg. 1994;107:615\u201320.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"9223_CR3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejcts.2004.03.043","volume":"26","author":"S Takeda","year":"2004","unstructured":"Takeda S, et al. Thymic carcinoma. Clinical institutional experience with 15 patients. Eur J Cardiothorac Surg. 2004;26:401\u20136. doi: 10.1016\/j.ejcts.2004.03.043 .","journal-title":"Eur J Cardiothorac Surg"},{"key":"9223_CR4","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cncr.11606","volume":"98","author":"K Yoh","year":"2004","unstructured":"Yoh K, et al. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma. Cancer. 2004;98:926\u201331. doi: 10.1002\/cncr.11606 .","journal-title":"Cancer"},{"key":"9223_CR5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00000421-200206000-00012","volume":"25","author":"T Koizumi","year":"2002","unstructured":"Koizumi T, et al. Chemotherapy for advanced thymic carcinoma Clinical responsive for cisplatin, doxorubicin, vincristine and cyclophosphamide (ADOC chemotherapy). Am J Clin Oncol. 2002;25:266\u20138. doi: 10.1097\/00000421-200206000-00012 .","journal-title":"Am J Clin Oncol"},{"key":"9223_CR6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jjco\/hye136","volume":"31","author":"A Kitami","year":"2001","unstructured":"Kitami A, Suzuki T, Kamio Y, Suzuki S. Chemotherapy of thymic carcinoma: analysis of seven cases and review of the literature. Jpn J Clin Oncol. 2001;31:601\u20134. doi: 10.1093\/jjco\/hye136 .","journal-title":"Jpn J Clin Oncol"},{"key":"9223_CR7","first-page":"1485","volume":"15","author":"H Yanagawa","year":"1995","unstructured":"Yanagawa H, et al. Thymic carcinoma treated with intensive chemotherapy and radiation. Anticancer Res. 1995;15:1485\u20139.","journal-title":"Anticancer Res"},{"key":"9223_CR8","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/1097-0142(19901115)66:10<2092::AID-CNCR2820661008>3.0.CO;2-1","volume":"66","author":"RW Carlson","year":"1990","unstructured":"Carlson RW, Dorfman RF, Sikic BI. Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy. Cancer. 1990;66:2092\u20134. doi: 10.1002\/1097-0142(19901115)66:10<2092::AID-CNCR2820661008>3.0.CO;2-1 .","journal-title":"Cancer"},{"key":"9223_CR9","first-page":"4098","volume":"49","author":"Y Ohe","year":"1989","unstructured":"Ohe Y, et al. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines. Cancer Res. 1989;49:4098\u2013102.","journal-title":"Cancer Res"},{"key":"9223_CR10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1349-7006.1998.tb00519.x","volume":"89","author":"M Hanada","year":"1998","unstructured":"Hanada M, et al. A new antitumor agent amrubicin induces cell growth inhibition by stabilizing topoisomerase II-DNA complex. Jpn J Cancer Res. 1998;89:1229\u201338.","journal-title":"Jpn J Cancer Res"},{"key":"9223_CR11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1349-7006.2007.00404.x","volume":"98","author":"M Hanada","year":"2007","unstructured":"Hanada M, Noguchi T, Yamaoka T. Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in\u00a0vitro and in\u00a0vivo. Cancer Sci. 2007;98:447\u201354. doi: 10.1111\/j.1349-7006.2007.00404.x .","journal-title":"Cancer Sci"},{"key":"9223_CR12","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1200\/JCO.2006.08.4145","volume":"24","author":"S Onoda","year":"2006","unstructured":"Onoda S, et al. Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301. J Clin Oncol. 2006;24:5448\u201353. doi: 10.1200\/JCO.2006.08.4145 .","journal-title":"J Clin Oncol"},{"key":"9223_CR13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/annonc\/mdi081","volume":"16","author":"Y Ohe","year":"2005","unstructured":"Ohe Y, et al. Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer. Ann Oncol. 2005;16:430\u20136. doi: 10.1093\/annonc\/mdi081 .","journal-title":"Ann Oncol"},{"key":"9223_CR14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/jjco\/hyi217","volume":"36","author":"J Ikeda","year":"2006","unstructured":"Ikeda J, et al. Phase I study of amrubicin hydrochloride and cisplatin in patients previously treated for advanced non-small cell lung cancer. Jpn J Clin Oncol. 2006;36:12\u20136. doi: 10.1093\/jjco\/hyi217 .","journal-title":"Jpn J Clin Oncol"},{"key":"9223_CR15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01243894-200607000-00009","volume":"1","author":"A Inoue","year":"2006","unstructured":"Inoue A, et al. A phase I study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer. J Thorac Oncol. 2006;1:551\u20135. doi: 10.1097\/01243894-200607000-00009 .","journal-title":"J Thorac Oncol"},{"key":"9223_CR16","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","volume":"48","author":"A Masaoka","year":"1981","unstructured":"Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485\u201392. doi: 10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R .","journal-title":"Cancer"},{"key":"9223_CR17","unstructured":"National Cancer Institute: Common Toxicity Criteria (CTC) v 2.0. http:\/\/ctep.cancer.gov\/reporting\/ctc.html ."},{"key":"9223_CR18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205\u201316. doi: 10.1093\/jnci\/92.3.205 .","journal-title":"J Natl Cancer Inst"},{"key":"9223_CR19","first-page":"4851","volume":"26","author":"Y Komatsu","year":"2006","unstructured":"Komatsu Y, et al. Salvage chemotherapy with carboplatin and paclitaxel for cisplatin-resistant thymic carcinoma\u2014three cases. Anticancer Res. 2006;26:4851\u20135.","journal-title":"Anticancer Res"},{"key":"9223_CR20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/A:1005862730941","volume":"15","author":"T Suzuki","year":"1997","unstructured":"Suzuki T, Minamide S, Iwasaki T, Yamamoto H, Kanda H. Cardiotoxicity of a new anthracycline derivative (SM-5887) following intravenous administration to rabbits: comparative study with doxorubicin. Invest New Drugs. 1997;15:219\u201325. doi: 10.1023\/A:1005862730941 .","journal-title":"Invest New Drugs"},{"key":"9223_CR21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1006088907271","volume":"16","author":"T Noda","year":"1998","unstructured":"Noda T, Watanabe T, Kohda A, Hosokawa S, Suzuki T. Chronic effects of a novel synthetic anthracycline derivative (SM-5887) on normal heart and doxorubicin-induced cardiomyopathy in dogs. Invest New Drugs. 1998;16:121\u20138. doi: 10.1023\/A:1006088907271 .","journal-title":"Invest New Drugs"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9223-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-009-9223-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9223-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T22:44:40Z","timestamp":1589755480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-009-9223-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,5]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["9223"],"URL":"https:\/\/doi.org\/10.1007\/s12032-009-9223-y","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,5]]}}}